Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

MLA

Nin, Johanna W. M., et al. “Higher Plasma Soluble Receptor for Advanced Glycation End Products (SRAGE) Levels Are Associated with Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-up Study.” Diabetes, vol. 59, no. 8, Aug. 2010, p. 2027. EBSCOhost, https://doi.org/10.2337/db09-1509.

APA

Nin, J. W. M., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H.-H., Tarnow, L., Rossing, P., & Stehouwer, C. D. A. (2010, August 1). Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes, 59(8), 2027. https://doi.org/10.2337/db09-1509

Chicago

Nin, Johanna W.M., Anders Jorsal, Isabel Ferreira, Casper G. Schalkwijk, Martin H. Prins, Hans-Henrik Parving, Lise Tarnow, Peter Rossing, and Coen D.A. Stehouwer. 2010. “Higher Plasma Soluble Receptor for Advanced Glycation End Products (SRAGE) Levels Are Associated with Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-up Study.” Diabetes, August 1. doi:10.2337/db09-1509.